Swiss biotech company Evolva has launched L-arabinose, a natural “sugar blocker” used in food and beverages. The company is having commercial discussions with its major customers to supply the first volumes for 2021. L-arabinose’s taste profile is well-suited for use in products such as chocolate, ice cream, cereal, power bars and confectionery. With a wide range of applications, the substance has a current market value of CHF 250 m, which is expected to grow by at least 5 %/a, according to Evolva.

Studies show that L-arabinose (previously known as EVE-X157/Z4) as a sugar blocker can support healthy blood sugar levels and weight management. It also has potential application as a prebiotic. Made by fermentation methods, the product is fully renewable and sustainable. It has a high-purity level (more than 99 %) and no hydrochloric acid is used in the manufacturing process.